Could licorice help fight gum disease? new study says maybe
NCT ID NCT07422883
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a licorice extract gel could improve the results of deep cleaning for people with stage II periodontitis (moderate gum disease). Fifty patients were split into two groups: one got standard deep cleaning alone, and the other got deep cleaning plus licorice gel applied to the gum pockets twice a week for six weeks. The goal was to see if the gel reduced gum inflammation and lowered levels of a key inflammatory marker called interleukin-6.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- licorice extract gel (5% glycyrrhizin)
- What this could lead to
- If it works, this could point toward a natural, low-cost gel to improve gum health after standard deep cleaning.
- What could go wrong
- This is a small, early-stage study with only 20 treated patients. The results may not apply to everyone, and licorice gel is not a replacement for professional dental care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with Stage II Periodontitis (mainly horizontal bone loss with maximum probing depth ≤ 5 mm and with 3-4 mm clinical attachment loss). * Age range (30 - 50) years. * Good compliance with the plaque control instructions following initial therapy. * Availability for follow up and maintenance program. Exclusion Criteria: * Smoking. * Systemic diseases which could influence the outcome of the therapy (According to Cornell Medical Index-Health Questionnaire). * Pregnant and lactating females. * Vulnerable groups of patients' e.g (prisoners, disabled patients and decisionally impaired individuals).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Interleukin-6 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mansoura university
Al Mansurah, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Coconut oil takes on chlorhexidine in gum disease showdown
- Cycling tests reveal how Athletes' bodies respond to exercise stress
- Vaping vs smoking: which is worse for your gums?
- No-Opioid anesthesia may ease stress of major aneurysm surgery
- Could a green dye and laser light save your gums?
- Could honey help young glaucoma patients? new trial investigates